×
Pour une meilleure utilisation, nous vous conseillons d’activer Javascript dans votre navigateur.
VEGFR2/CD309 anticorps (pTyr1214)
VEGFR2
Reactivité: Humain, Souris, Rat
WB, IHC, ELISA
Hôte: Lapin
Polyclonal
unconjugated
N° du produit ABIN1580207
Détail du produit anti-VEGFR2/CD309 anticorps
(cache)
Antigène
Voir toutes VEGFR2/CD309 (VEGFR2) Anticorps
VEGFR2/CD309 (VEGFR2)
(VEGF Receptor 2 (VEGFR2))
Épitope
Tous les épitopes à travers VEGFR2/CD309 Anticorps.
pTyr1214
Reactivité
Toutes les réactivités sur VEGFR2/CD309 Anticorps
Humain, Souris, Rat
Hôte
Toutes les hôtes sur VEGFR2/CD309 Anticorps
Lapin
Clonalité
Toutes les clonalités sur VEGFR2/CD309 Anticorps
Polyclonal
Conjugué
Tous les conjugués à travers VEGFR2/CD309 Anticorps
Cet anticorp VEGFR2/CD309 est non-conjugé
Application
Tous les applications à travers VEGFR2/CD309 Anticorps.
Western Blotting (WB), Immunohistochemistry (IHC), ELISA
Specificité
Epitopes for Species: H:Y1214,M:Y1212,R:Y1210
Purification
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide was removed by chromatography using non-phosphopeptide corresponding to the phosphorylation site.
Immunogène
The antiserum was produced against synthesized phosphopeptide derived from human VEGFR2 around the phosphorylation site of tyrosine 1214 (F-H-YP-D-N).
Top Product
Discover our top product VEGFR2 Anticorps primaire
Alternatives
(show)
Information d'application
(cache)
Indications d'application
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Stockage
(cache)
Concentration
1 mg/mL
Buffer
Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
Stock
-20 °C
Stockage commentaire
Store at -20°C / 1 year
Date de péremption
12 months
Détails sur VEGFR2/CD309
(cache)
Antigène
VEGFR2/CD309 (VEGFR2)
(VEGF Receptor 2 (VEGFR2))
Autre désignation
VEGFR2 (VEGFR2 Produits )
Synonymes
anticorps CD309, anticorps FLK1, anticorps VEGFR, anticorps VEGFR2, anticorps 6130401C07, anticorps Flk-1, anticorps Flk1, anticorps Krd-1, anticorps Ly73, anticorps VEGFR-2, anticorps sVEGFR-2, anticorps Vegfr-2, anticorps FLK-1, anticorps flk-1, anticorps vegfr-2, anticorps KDR, anticorps FLK/KDR, anticorps flk1, anticorps flk1b, anticorps kdrb, anticorps si:busm1-205d10.1, anticorps si:ch211-254j6.1, anticorps si:ch211-278f21.4, anticorps wu:fc31a09, anticorps fk52c05, anticorps flk, anticorps kdr, anticorps kdra, anticorps vegfr2, anticorps vegfr4, anticorps vegr2, anticorps wu:fk52c05, anticorps kinase insert domain receptor, anticorps kinase insert domain protein receptor, anticorps vascular endothelial growth factor receptor kdr-like, anticorps kinase insert domain receptor (a type III receptor tyrosine kinase), anticorps kinase insert domain receptor like, anticorps KDR, anticorps Kdr, anticorps LOC100136647, anticorps kdr, anticorps kdrl
Sujet
EC 2.7.10.1, FLK1, KDR, kinase insert domain receptor, protein-tyrosine kinase receptor Flk-1, vascular endothelial growth factor receptor 2, VGFR2, VGR2
UniProt
P35968
Pathways
Signalisation RTK , Glycosaminoglycan Metabolic Process , Signaling Events mediated by VEGFR1 and VEGFR2 , Growth Factor Binding , Regulation of long-term Neuronal Synaptic Plasticity , VEGF Signaling
Vus récemment
(cache)